Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Tauns Laboratories, Inc. ( (JP:197A) ) is now available.
Tauns Laboratories, Inc. reported its financial results for the first half of fiscal year 2025, showing strong performance with net sales of 11,981 million yen and a net income of 4,686 million yen. The company also announced a forecast for continued growth in the fiscal year, with expected increases in net sales and income, reflecting its robust market positioning and effective operational strategies.
More about Tauns Laboratories, Inc.
Tauns Laboratories, Inc. is a company listed on the Tokyo Stock Exchange, operating in the pharmaceutical industry. It focuses primarily on research and development of laboratory products and services, catering to various medical and scientific sectors.
YTD Price Performance: -5.80%
Average Trading Volume: 1,026,986
Technical Sentiment Consensus Rating: Strong Sell
For detailed information about 197A stock, go to TipRanks’ Stock Analysis page.